Cargando…

Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer

Endocrine treatment represents the cornerstone of endocrine-sensitive premenopausal early breast cancer. The estrogen blockade plays a leading role in the therapeutic management of hormone receptor-positive breast cancer together with surgery, radiotherapy, and selective antiestrogen treatments. For...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venturelli, Marta, Guaitoli, Giorgia, Omarini, Claudia, Moscetti, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844254/ https://www.ncbi.nlm.nih.gov/pubmed/29551913 http://dx.doi.org/10.2147/BCTT.S137508

Ejemplares similares

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
por: Omarini, Claudia, et al.
Publicado: (2018)

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus
por: Omarini, Claudia, et al.
Publicado: (2018)

Contraceptive Use in Premenopausal Women With Early Breast Cancer
por: Lambertini, Matteo, et al.
Publicado: (2022)

Triptorelin for the treatment of adenomyosis: A multicenter observational study of 465 women in Russia
por: Andreeva, Elena, et al.
Publicado: (2020)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer
por: Turnbull, Arran K., et al.
Publicado: (2020)

Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
por: Toss, A., et al.
Publicado: (2021)

Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer
por: Parisi, Francesca, et al.
Publicado: (2020)

Role of Ovarian Function Suppression in Premenopausal Women with Early Breast Cancer
por: Park, Woo-Chan
Publicado: (2016)

Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab
por: Bagegni, Nusayba A, et al.
Publicado: (2022)

Comparison of changes in lipid profiles of premenopausal women with early-stage breast cancer treated with different endocrine therapies
por: Wang, Kaiyue, et al.
Publicado: (2022)

Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review
por: Canino, Fabio, et al.
Publicado: (2022)

Central Precocious Puberty: Treatment with Triptorelin 11.25 mg
por: Chiocca, Elena, et al.
Publicado: (2012)

Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea
por: Abbara, Ali, et al.
Publicado: (2023)

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy
por: Toss, Angela, et al.
Publicado: (2022)

Birth characteristics of premenopausal women with breast cancer.
por: Le Marchand, L., et al.
Publicado: (1988)

Ovarian reserve in premenopausal women with breast cancer
por: Zong, Xiangyun, et al.
Publicado: (2022)

Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature
por: Isca, Chrystel, et al.
Publicado: (2021)

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer
por: Hackshaw, Allan, et al.
Publicado: (2009)

The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer
por: Blondeaux, Eva, et al.
Publicado: (2021)

Clinical outcome of one-third–dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation
por: Li, Yu, et al.
Publicado: (2012)

Ovarian preservation for premenopausal women with early-stage endometrial cancer: a Chinese retrospective study
por: Lyu, Tianjiao, et al.
Publicado: (2019)

Physical activity and risk of breast cancer in premenopausal women
por: Colditz, G A, et al.
Publicado: (2003)

Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)

Inclusion of premenopausal women in breast cancer clinical trials
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Genomic signature of parity in the breast of premenopausal women
por: Santucci-Pereira, Julia, et al.
Publicado: (2019)

Lipidome of mammographic breast density in premenopausal women
por: Getz, Kayla R., et al.
Publicado: (2023)

Synthesis of Triptorelin Lactate Catalyzed by Lipase in Organic Media
por: Zhuang, Hong, et al.
Publicado: (2012)

380 Presentation of Three Cases of Allergic Reactions to Triptorelin
por: Diaz, Maria Cristina, et al.
Publicado: (2012)

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials
por: Omarini, Claudia, et al.
Publicado: (2020)

Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women
por: Han, Yunan, et al.
Publicado: (2022)

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications
por: Toss, Angela, et al.
Publicado: (2018)

Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer
por: Gupta, Aanchal, et al.
Publicado: (2021)

Study of the availability of digital mammography for premenopausal women in the Valencian Breast Cancer Early Detection Program
por: Ramos, M, et al.
Publicado: (2008)

An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer
por: Merseburger, Axel S., et al.
Publicado: (2016)

Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer
por: Breul, Jürgen, et al.
Publicado: (2016)

Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges
por: Cerma, Krisida, et al.
Publicado: (2023)

IMPACT OF BODY COMPOSITION ON THE QUALITY OF LIFE OF PREMENOPAUSAL PATIENTS WITH EARLY STAGE BREAST CANCER DURING CHEMOTHERAPY
por: Pavlović Mavić, Mirjana, et al.
Publicado: (2022)

Coffee, Tea, and Mammographic Breast Density in Premenopausal Women
por: Odama, Adashi Margaret, et al.
Publicado: (2021)

Hyperprolactinaemia is common in Chinese premenopausal women with breast diseases
por: Zhu, Jiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_am4qguc3qdbd93bg04e915c1gd